Position in CRBU
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$492,420
-$521,594 QoQ
Shares Held
259,169
-59.4% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 137 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 99.45981193738449.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5401880626155134.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. CRBU ranks #286 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in CRBU
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $492,420 | 259,169 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,014,014 | 637,745 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $743,950 | 319,292 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $313,869 | 249,103 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $532,166 | 582,878 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $630,223 | 396,367 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $308,343 | 157,318 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $174,719 | 106,536 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,098,533 | 408,275 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,871,011 | 326,529 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $724,198 | 151,506 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $492,481 | 115,878 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $742,099 | 139,755 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,222,407 | 194,651 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $515,915 | 48,902 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $75,188 | 13,847 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $143,584 | 15,641 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $270,624 | 17,934 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $213,826 | 8,958 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||